Private company

OPIANT PHARMACEUTICALS, INC.

OPIANT PHARMACEUTICALS, INC. is a pharmaceutical preparations company.1 It is headquartered in Santa Monica, California.1

Last updated Oct 20, 2026.

Overview

  • IndustryPharmaceutical Preparations1
  • HeadquartersSanta Monica, California1
  • Business address233 Wilshire Blvd, Suite 400, Santa Monica, Ca 904012
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

10.8%Operating margin3
6.3%Net margin3
61.3%Revenue growth, 20213
6.4%Return on equity3
$1.9MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2021

  • Research and development35¢$16.8M
  • Other costs54¢$25.8M
  • Interest4¢$2.1M
  • Income tax0¢$24.3K
  • Profit6¢$3.0M

Out of $47.8M in revenue.3

Where each dollar of operating cash went, fiscal 2021

  • Kept or used elsewhere100¢$1.9M

Out of $1.9M of cash from operations.3

Financial statements

Revenue45673$47.8M in 2021+2983% since 2015
0$20.0M$40.0M$60.0M2015: $1.6M$1.6M20152016: $9.9M$9.9M2016+539%2017: $15.6M$15.6M2017+57%2018: $14.0M$14.0M2018−10%2019: $40.5M$40.5M2019+190%2020: $29.6M$29.6M2020−27%2021: $47.8M$47.8M2021+61%
Operating income456873$5.2M in 2021
-$30.0M-$20.0M-$10.0M0$10.0M$20.0M2015: -$6.9M-$6.9M20152016: -$7.7M-$7.7M2016+12%2017: -$1.9M-$1.9M2017−76%2018: -$21.2M-$21.2M2018+1029%2019: $10.9M$10.9M20192020: -$2.2M-$2.2M20202021: $5.2M$5.2M2021
Net income456873$3.0M in 2021
-$30.0M-$20.0M-$10.0M0$10.0M$20.0M2015: -$7.0M-$7.0M20152016: -$7.8M-$7.8M2016+11%2017: -$2.6M-$2.6M2017−67%2018: -$21.2M-$21.2M2018+713%2019: $11.6M$11.6M20192020: -$1.9M-$1.9M20202021: $3.0M$3.0M2021
Fiscal year2015201620172018201920202021
Revenue$1.6M4$9.9M5$15.6M6$14.0M6$40.5M7$29.6M3$47.8M3
Cost of revenue$13.7M8$08
Research and development$2.4M4$2.8M5$4.9M6$8.5M8$9.1M7$9.2M3$16.8M3
Operating expenses$42.6M3
Operating income-$6.9M4-$7.7M5-$1.9M6-$21.2M8$10.9M7-$2.2M3$5.2M3
Interest$28.2K11$07$131.0K3$2.1M3
Income before tax$3.0M3
Income tax$04$550.5K6$797.0K6$51.3K8-$177.2K7-$425.7K3$24.3K3
Net income-$7.0M4-$7.8M5-$2.6M6-$21.2M8$11.6M7-$1.9M3$3.0M3
Earnings per share-$4.095$3.276-$7.108$2.887-$0.443$0.683
Earnings per share (diluted)-$4.095$2.946-$7.108$2.177-$0.443$0.513
Shares (weighted, basic)4.5M shares3
Shares (weighted, diluted)5.9M shares3

Compare OPIANT PHARMACEUTICALS, INC. with another company

Corporate structure

OPIANT PHARMACEUTICALS, INC. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of OPIANT PHARMACEUTICALS, INC.

  • Western Standard LLC Filed SC 13G/A on OPIANT PHARMACEUTICALS, INC., latest Feb 15, 2023 (2 filings since Nov 28, 2022)
  • Michael Sinclair Filed SC 13D/A on OPIANT PHARMACEUTICALS, INC., latest Jun 17, 2022
  • Roger Crystal Filed SC 13D/A on OPIANT PHARMACEUTICALS, INC., latest Jun 17, 2022
  • RENAISSANCE TECHNOLOGIES LLC Filed SC 13G/A on OPIANT PHARMACEUTICALS, INC., latest Feb 10, 2022
  • Wells Fargo Filed SC 13G/A on OPIANT PHARMACEUTICALS, INC., latest Jan 27, 2022
  • OPIANT PHARMACEUTICALS, INC. Santa Monica, California

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What OPIANT PHARMACEUTICALS, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$78.1K3 Dec 31, 2021$171.2K3 Dec 31, 2020−54.4%
Operating-lease assets (leased space)$999.6K3 Dec 31, 2021$278.5K3 Dec 31, 2020+259.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$37.9M3 Dec 31, 2021$48.3M3 Dec 31, 2020−21.5%
Marketable securities, current$15.0M3 Dec 31, 2021$03 Dec 31, 2020

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$11.6K3 Dec 31, 2021$13.0K3 Dec 31, 2020−10.6%

Leadership

Who has led OPIANT PHARMACEUTICALS, INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Roger Crystal2015–2023

Chair

  1. Michael Sinclair2015–2017

Chief financial officer

  1. Kevin Pollack2012–2015
2010201520202025
Board members and other officers (14)

Former names

  • Lightlake Therapeutics Inc.Sep 28, 2009 to Jan 22, 20162
  • Madrona Ventures, Inc.Jan 11, 2007 to Oct 9, 20092

Timeline

  1. Mar 2, 20238-K Ended a material agreement; Completed an acquisition or sale; Listing notice or transfer26
  2. Mar 1, 20238-K Shareholder vote27
  3. Feb 27, 20238-K Executive or director change28
  4. Feb 7, 20238-K Other events29
  5. Jan 9, 20238-K Executive or director change30
  6. Nov 15, 20228-K Entered a material agreement; Ended a material agreement; New debt or obligation31
  7. Nov 14, 20228-K Results of operations32
  8. Aug 11, 20228-K Financial statements and exhibits33
  9. Jun 14, 20228-K Shareholder vote34
  10. Jun 8, 20228-K Entered a material agreement35
  11. May 10, 20228-K Results of operations36
  12. Apr 27, 20228-K Other events37
  13. Oct 30, 2015New chief executive Roger Crystal becomes CEO12

Calendar

When it reported results

  1. Nov 14, 2022Reported quarterly or annual results32
  2. May 10, 2022Reported quarterly or annual results36
  3. Mar 15, 2022Reported quarterly or annual results38
  4. Nov 12, 2021Reported quarterly or annual results39

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

116 filings to the SEC since October 2021: 1 annual reports, 4 quarterly reports, 17 major events, 65 insider forms, 6 large holders, 23 other. The latest 20:

  1. Jul 11, 2023CT ORDER EDGAR
  2. Mar 13, 202315-12G EDGAR
  3. Mar 9, 2023EFFECT EDGAR
  4. Mar 9, 2023EFFECT EDGAR
  5. Mar 9, 2023EFFECT EDGAR
  6. Mar 6, 2023POS AM EDGAR
  7. Mar 6, 2023POS AM EDGAR
  8. Mar 6, 2023POS AM EDGAR
  9. Mar 6, 2023S-8 POS EDGAR
  10. Mar 6, 2023S-8 POS EDGAR
  11. Mar 6, 2023S-8 POS EDGAR
  12. Mar 6, 2023S-8 POS EDGAR
  13. Mar 6, 2023S-8 POS EDGAR
  14. Mar 6, 2023S-8 POS EDGAR
  15. Mar 3, 20234 EDGAR
  16. Mar 3, 20234 EDGAR
  17. Mar 3, 20234 EDGAR
  18. Mar 3, 20234 EDGAR
  19. Mar 3, 20234 EDGAR
  20. Mar 3, 20234 EDGAR

The 116 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

39 open-market trades by officers, directors and large owners since October 2021: 6 buys and 33 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jan 27, 2023CRYSTAL ROGERChief Executive OfficerSale1,358$20.26$27.5KForm 4
Jan 27, 2023Ellison Mark Jason HeathChief Development OfficerSale610$20.26$12.4KForm 4
Jan 27, 2023Gorman BrianSale444$20.26$9.0KForm 4
Jan 27, 2023Skolnick PhilChief Scientific OfficerSale480$20.26$9.7KForm 4
Jan 27, 2023O'Toole David DChief Financial OfficerSale541$20.26$11.0KForm 4
Jan 9, 2023O'Toole David DChief Financial OfficerSale415$20.20$8.4KForm 4
Jan 9, 2023Ellison Mark Jason HeathChief Development OfficerSale469$20.20$9.5KForm 4
Jan 9, 2023Skolnick PhilChief Scientific OfficerSale369$20.20$7.5KForm 4
Jan 9, 2023CRYSTAL ROGERChief Executive OfficerSale1,183$20.20$23.9KForm 4
Jan 5, 2023Ellison Mark Jason HeathChief Development OfficerSale1,806$20.20$36.5KForm 4
Jan 5, 2023O'Toole David DChief Financial OfficerSale1,600$20.20$32.3KForm 4
Jan 5, 2023Gorman BrianSale1,313$20.20$26.5KForm 4
Jan 5, 2023Skolnick PhilChief Scientific OfficerSale1,421$20.20$28.7KForm 4
Jan 5, 2023CRYSTAL ROGERChief Executive OfficerSale5,029$20.20$101.6KForm 4
Jul 20, 2022Ruth Matthew R.Chief Commercial OfficerSale1,084$10.62$11.5KForm 4
Jul 14, 2022O'Toole David DChief Financial OfficerSale779$11.10$8.6KForm 4
Jul 14, 2022Skolnick PhilChief Scientific OfficerSale627$11.85$7.4KForm 4
Jul 14, 2022Gorman BrianSale691$11.16$7.7KForm 4
Jul 14, 2022CRYSTAL ROGERChief Executive OfficerSale2,246$11.11$25.0KForm 4
Jun 15, 2022Sinclair MichaelDirectorSale900$10.60$9.5KForm 4

All 39 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How OPIANT PHARMACEUTICALS, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGAROPIANT PHARMACEUTICALS, INC.1
  • CIK0001385508
  • Employer ID (EIN)46-47441241
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • Business address233 Wilshire Blvd, Suite 400, Santa Monica, CA 904011
  • Phone(310) 598-54101
  • Shares outstanding5,167,814 as of Nov 10, 202210
  • Public float$55.2M as of Jun 30, 20213
  • On EDGAR sinceJan 11, 20071
  • Filings578 in all: 4 (182), 8-K (150), 10-Q (43), 3 (18), UPLOAD (16), 10-K (14), CORRESP (12), DEFA14A (12)1
    All 47 form types

    10-Q/A (10), SC 13G/A (10), DEF 14A (9), CT ORDER (8), EFFECT (7), SC 13G (7), S-8 (6), S-8 POS (6), 10QSB (5), 8-K/A (5), SC 13D/A (5), 10-K/A (4), 424B5 (4), DFAN14A (4), S-1/A (4), 4/A (3), POS AM (3), PRE 14A (3), S-3 (3), SC 13D (3), 424B3 (2), NT 10-Q (2), PREM14A (2), 10-KT (1), 10KSB (1), 10KSB/A (1), 15-12G (1), 25-NSE (1), 5 (1), 8-A12B (1), 8-A12G (1), ARS (1), CERTNAS (1), DEFM14A (1), NT 10-K (1), RW (1), S-1 (1), SB-2 (1), SB-2/A (1)

  • Latest filingsAnnual report (10-K) Mar 15, 2022
    Quarterly report (10-Q) Nov 14, 2022
    Proxy statement (DEF 14A) Apr 18, 2022
    Latest 8-K (8-K) Mar 2, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
    SEC EDGAROther events
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
    SEC EDGAROther events
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44